Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126909271 | 12690927 | 1 | I | 2014 | 20160429 | 20160826 | 20160826 | EXP | PE-009507513-1605PER001385 | MERCK | 70.00 | YR | F | Y | 0.00000 | 20160826 | CN | PE | PE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126909271 | 12690927 | 1 | PS | JANUMET | METFORMIN HYDROCHLORIDESITAGLIPTIN PHOSPHATE | 1 | Oral | 50/500 MG, QD | 22044 | 1 | DF | FILM-COATED TABLET | QD | ||||||
126909271 | 12690927 | 2 | SS | JANUMET | METFORMIN HYDROCHLORIDESITAGLIPTIN PHOSPHATE | 1 | Oral | 1/2 TABLET, QD | 22044 | .5 | DF | FILM-COATED TABLET | QD | ||||||
126909271 | 12690927 | 3 | C | IRBESARTAN. | IRBESARTAN | 1 | Oral | TOTAL DAILY DOSE: 300 MG, BID | 0 | TABLET | BID | ||||||||
126909271 | 12690927 | 4 | C | ATENOLOL. | ATENOLOL | 1 | Oral | 50 MG, QD | 0 | 50 | MG | TABLET | QD | ||||||
126909271 | 12690927 | 5 | C | NIFEDIPINE. | NIFEDIPINE | 1 | Oral | 30 MG, TID | 0 | 30 | MG | TABLET | TID | ||||||
126909271 | 12690927 | 6 | C | LEVEMIR | INSULIN DETEMIR | 1 | Subcutaneous | 20 IU, QD | 0 | 20 | IU | INJECTION | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126909271 | 12690927 | 1 | Diabetes mellitus |
126909271 | 12690927 | 3 | Hypertension |
126909271 | 12690927 | 4 | Hypertension |
126909271 | 12690927 | 5 | Hypertension |
126909271 | 12690927 | 6 | Diabetes mellitus |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126909271 | 12690927 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126909271 | 12690927 | Bile duct stone | |
126909271 | 12690927 | Chronic kidney disease | |
126909271 | 12690927 | Diarrhoea | |
126909271 | 12690927 | Haematuria | |
126909271 | 12690927 | Haemoglobin decreased | |
126909271 | 12690927 | Inappropriate schedule of drug administration | |
126909271 | 12690927 | Renal disorder | |
126909271 | 12690927 | Visual acuity reduced |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126909271 | 12690927 | 1 | 2014 | 201508 | 0 | |
126909271 | 12690927 | 2 | 201508 | 0 | ||
126909271 | 12690927 | 6 | 2015 | 0 |